These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 9223227)
21. Characterization of a low molecular weight isoform of IL-1 receptor antagonist. Malyak M; Guthridge JM; Hance KR; Dower SK; Freed JH; Arend WP J Immunol; 1998 Aug; 161(4):1997-2003. PubMed ID: 9712072 [TBL] [Abstract][Full Text] [Related]
22. Molecular cloning and cartilage gene expression of equine stromelysin 1 (matrix metalloproteinase 3). Balkman CE; Nixon AJ Am J Vet Res; 1998 Jan; 59(1):30-6. PubMed ID: 9442239 [TBL] [Abstract][Full Text] [Related]
23. Molecular cloning, sequencing, and expression of equine interleukin-6. Swiderski CE; Sobol G; Lunn DP; Horohov DW Vet Immunol Immunopathol; 2000 Dec; 77(3-4):213-20. PubMed ID: 11137120 [TBL] [Abstract][Full Text] [Related]
24. Expression of interleukin-1 receptor antagonist in human pituitary adenomas in vitro. Sauer J; Arzt E; Gumprecht H; Hopfner U; Stalla GK J Clin Endocrinol Metab; 1994 Dec; 79(6):1857-63. PubMed ID: 7989495 [TBL] [Abstract][Full Text] [Related]
25. Release kinetics of tumor necrosis factor-α and interleukin-1 receptor antagonist in the equine whole blood. Rütten S; Schusser GF; Abraham G; Schrödl W BMC Vet Res; 2016 Jun; 12(1):117. PubMed ID: 27316332 [TBL] [Abstract][Full Text] [Related]
26. Human interleukin-1 receptor antagonist. High yield expression in E. coli and examination of cysteine residues. Steinkasserer A; Solari R; Mott HR; Aplin RT; Robinson CC; Willis AC; Sim RB FEBS Lett; 1992 Sep; 310(1):63-5. PubMed ID: 1388125 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector. Roessler BJ; Hartman JW; Vallance DK; Latta JM; Janich SL; Davidson BL Hum Gene Ther; 1995 Mar; 6(3):307-16. PubMed ID: 7779914 [TBL] [Abstract][Full Text] [Related]
28. Molecular cloning and expression of equine interleukin 2. Vandergrifft EV; Horohov DW Vet Immunol Immunopathol; 1993 Dec; 39(4):395-406. PubMed ID: 8116217 [TBL] [Abstract][Full Text] [Related]
29. Deletion mutants of human interleukin 1 beta with significantly reduced agonist properties: search for the agonist/antagonist switch in ligands to the interleukin 1 receptors. Simoncsits A; Bristulf J; Tjörnhammar ML; Cserzö M; Pongor S; Rybakina E; Gatti S; Bartfai T Cytokine; 1994 Mar; 6(2):206-14. PubMed ID: 8032002 [TBL] [Abstract][Full Text] [Related]
30. Interleukin-1 receptor antagonist: role in biology. Arend WP; Malyak M; Guthridge CJ; Gabay C Annu Rev Immunol; 1998; 16():27-55. PubMed ID: 9597123 [TBL] [Abstract][Full Text] [Related]
31. cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Haskill S; Martin G; Van Le L; Morris J; Peace A; Bigler CF; Jaffe GJ; Hammerberg C; Sporn SA; Fong S Proc Natl Acad Sci U S A; 1991 May; 88(9):3681-5. PubMed ID: 1827201 [TBL] [Abstract][Full Text] [Related]
32. Mapping receptor binding sites in interleukin (IL)-1 receptor antagonist and IL-1 beta by site-directed mutagenesis. Identification of a single site in IL-1ra and two sites in IL-1 beta. Evans RJ; Bray J; Childs JD; Vigers GP; Brandhuber BJ; Skalicky JJ; Thompson RC; Eisenberg SP J Biol Chem; 1995 May; 270(19):11477-83. PubMed ID: 7744786 [TBL] [Abstract][Full Text] [Related]
33. Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves' orbital fibroblasts. Mühlberg T; Heberling HJ; Joba W; Schworm HD; Heufelder AE Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1018-28. PubMed ID: 9112998 [TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody based enzyme-linked and chemiluminescent assays for the human interleukin-1 receptor antagonist. Application to measure hIL-1ra levels in monocyte cultures and synovial fluids. Towbin H; Schmitz A; van Oostrum J; Seitz M; Dewald B; Zingel O; Motz J; Vosbeck K; Rordorf C J Immunol Methods; 1994 Mar; 170(1):125-35. PubMed ID: 8157985 [TBL] [Abstract][Full Text] [Related]
35. In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. Fernandes J; Tardif G; Martel-Pelletier J; Lascau-Coman V; Dupuis M; Moldovan F; Sheppard M; Krishnan BR; Pelletier JP Am J Pathol; 1999 Apr; 154(4):1159-69. PubMed ID: 10233854 [TBL] [Abstract][Full Text] [Related]
36. The mouse interleukin 1 receptor antagonist protein: gene structure and regulation in vitro. Zahedi KA; Uhlar CM; Rits M; Prada AE; Whitehead AS Cytokine; 1994 Jan; 6(1):1-9. PubMed ID: 8003626 [TBL] [Abstract][Full Text] [Related]
37. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Vannier E; Miller LC; Dinarello CA Proc Natl Acad Sci U S A; 1992 May; 89(9):4076-80. PubMed ID: 1533284 [TBL] [Abstract][Full Text] [Related]
38. Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist. Butcher C; Steinkasserer A; Tejura S; Lennard AC J Immunol; 1994 Jul; 153(2):701-11. PubMed ID: 8021506 [TBL] [Abstract][Full Text] [Related]
39. Sequence analysis of canine and equine ferritin H and L subunit cDNAs. Orino K; Miura T; Muto S; Watanabe K DNA Seq; 2005 Feb; 16(1):58-64. PubMed ID: 16040348 [TBL] [Abstract][Full Text] [Related]
40. Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis. Son K; Tomita Y; Shimizu T; Nishinarita S; Sawada S; Horie T Intern Med; 2000 Feb; 39(2):128-35. PubMed ID: 10732829 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]